Johnson & Johnson (JNJ) Tops Q2 EPS by 6c; Boosts FY16 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
BMO Capital Reiterates Outperform on Johnson & Johnson (JNJ) Following 2Q Report
July 20, 2016 10:39 AM EDTBMO Capital reiterated an Outperform rating and $132.00 price target on Johnson & Johnson (NYSE: JNJ) following the company's 2Q earnings report. JNJ reported revenue of $18.48B, ahead of the consensus estimate of $17.98 billion. EPS of $1.74 was also above the consensus estimates at $1.68.
Analyst Joanne... More
